Please enable JavaScript to continue using this application.

Compare $APLM vs $GOSS | Chartloom

Compare

$APLM vs $GOSS

Apollomics Inc · Gossamer Bio Inc

APLM

Apollomics Inc

GOSS

Gossamer Bio Inc

Compare $APLM vs $GOSS

Comparing Apollomics Inc and Gossamer Bio Inc

APLMApollomics Inc

GOSSGossamer Bio Inc

APLMApollomics Inc

Market cap

$47M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

11.4%

52W performance

413.1%

FCF yield

-1.7%

GOSSGossamer Bio Inc

Market cap

$4.55B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

32.4%

YTD performance

-96.0%

52W performance

-95.2%

FCF yield

-3.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APLM

GOSS

Detailed metrics comparison

APLM

Apollomics Inc

GOSS

Gossamer Bio Inc

Market Cap

APLM$47M

GOSS$4.55B

Enterprise Value

APLM$47M

GOSS$4.55B

Price

APLM$21.50

GOSS$9.31

P/E Ratio

APLMN/A

GOSSN/A

P/S Ratio

APLM0.00x

GOSS85.41x

EV/Sales

APLM0.00x

GOSS85.32x

EV/EBITDA

APLM0.00x

GOSS0.00x

P/B Ratio

APLM13.94x

GOSS2.26x

P/FCF Ratio

APLMN/A

GOSSN/A

EV/FCF

APLM-57.95x

GOSS-27.95x

PEG Ratio

APLMN/A

GOSSN/A

Forward P/E (NTM)

APLMN/A

GOSSN/A

Forward P/S (NTM)

APLMN/A

GOSSN/A

Revenue (TTM)

APLM$0

GOSS$53M

Revenue Growth (YoY)

APLMN/A

GOSS32.4%

Forward Rev Growth

APLM0.0%

GOSS50.5%

Gross Margin (TTM)

APLM0.0%

GOSS0.0%

Operating Margin (TTM)

APLM0.0%

GOSS0.0%

EBITDA Margin (TTM)

APLM0.0%

GOSS-297.6%

Net Margin (TTM)

APLM0.0%

GOSS-235.0%

FCF Margin (TTM)

APLMN/A

GOSS-305.2%

Net Income (TTM)

APLM$-823K

GOSS$-125M

FCF (TTM)

APLM$-814K

GOSS$-163M

EPS (TTM)

APLM-$0.06

GOSS-$0.38

ROE (TTM)

APLM-69339.0%

GOSS-11877.0%

ROA (TTM)

APLM-26328.0%

GOSS-8535.0%

ROIC (TTM)

APLM-56760.0%

GOSS-2300.0%

Cash

APLM$134K

GOSS$41M

Debt

APLM$0

GOSS$36M

Net Cash/Debt

APLM$134K

GOSS$5M

Current Ratio (TTM)

APLM0.96x

GOSS0.53x

Quick Ratio (TTM)

APLM0.88x

GOSS0.46x

Debt/Equity (TTM)

APLM0.20x

GOSS6.83x

Debt/Assets (TTM)

APLM0.0%

GOSS0.0%

Interest Coverage (TTM)

APLMN/A

GOSSN/A

Net Debt/EBITDA (TTM)

APLM0.00x

GOSS0.00x

Beta

APLM1.37

GOSS2.28

52W Performance

APLM413.1%

GOSS-95.2%

YTD Performance

APLM11.4%

GOSS-96.0%

% from 52W High

APLM-49.0%

GOSS-97.0%

% from 52W Low

APLM410.7%

GOSS2.3%

Asset Turnover (TTM)

APLM0.00x

GOSS0.36x

FCF Yield (TTM)

APLM-1.7%

GOSS-3.6%

Earnings Yield (TTM)

APLM-1.7%

GOSS-2.8%

Dividend Yield (TTM)

APLMN/A

GOSSN/A

Rule of 40

APLM0.0

GOSS-272.8

EV/GP/RG

APLMN/A

GOSSN/A

Ticker research

View APLM research View GOSS research

Metric	APLM Apollomics Inc	GOSS Gossamer Bio Inc
Market & Valuation
Market Cap	$47M	$4.55B
Enterprise Value	$47M	$4.55B
Price	$21.50	$9.31
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	85.41x
EV/Sales	0.00x	85.32x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.94x	2.26x
P/FCF Ratio	N/A	N/A
EV/FCF	-57.95x	-27.95x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$53M
Revenue Growth (YoY)	N/A	32.4%
Forward Rev Growth	0.0%	50.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-297.6%
Net Margin (TTM)	0.0%	-235.0%
FCF Margin (TTM)	N/A	-305.2%
Net Income (TTM)	$-823K	$-125M
FCF (TTM)	$-814K	$-163M
EPS (TTM)	-$0.06	-$0.38
ROE (TTM)	-69339.0%	-11877.0%
ROA (TTM)	-26328.0%	-8535.0%
ROIC (TTM)	-56760.0%	-2300.0%
Financial Health
Cash	$134K	$41M
Debt	$0	$36M
Net Cash/Debt	$134K	$5M
Current Ratio (TTM)	0.96x	0.53x
Quick Ratio (TTM)	0.88x	0.46x
Debt/Equity (TTM)	0.20x	6.83x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	2.28
52W Performance	413.1%	-95.2%
YTD Performance	11.4%	-96.0%
% from 52W High	-49.0%	-97.0%
% from 52W Low	410.7%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.36x
FCF Yield (TTM)	-1.7%	-3.6%
Earnings Yield (TTM)	-1.7%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-272.8
EV/GP/RG	N/A	N/A
Ticker research	View APLM research	View GOSS research

Valuation

P/S Ratio

APLM

0.00x

GOSS

85.41x

EV/FCF

APLM

-57.95x

GOSS

-27.95x

Growth & revenue

Revenue Growth TTM

GOSS

32.4%

Forward Revenue Growth

GOSS

50.5%

APLM

0.0%

Profitability & performance

Gross Margin

APLM

0.0%

GOSS

0.0%

ROE

GOSS

-11877.0%

APLM

-69339.0%

FCF Yield %

APLM

-1.7%

GOSS

-3.6%

52-Week Performance

APLM

413.1%

GOSS

-95.2%

Detailed metrics comparison

APLM

Apollomics Inc

GOSS

Gossamer Bio Inc

Market Cap

APLM$47M

GOSS$4.55B

Enterprise Value

APLM$47M

GOSS$4.55B

Price

APLM$21.50

GOSS$9.31

P/E Ratio

APLMN/A

GOSSN/A

P/S Ratio

APLM0.00x

GOSS85.41x

EV/Sales

APLM0.00x

GOSS85.32x

EV/EBITDA

APLM0.00x

GOSS0.00x

P/B Ratio

APLM13.94x

GOSS2.26x

P/FCF Ratio

APLMN/A

GOSSN/A

EV/FCF

APLM-57.95x

GOSS-27.95x

PEG Ratio

APLMN/A

GOSSN/A

Forward P/E (NTM)

APLMN/A

GOSSN/A

Forward P/S (NTM)

APLMN/A

GOSSN/A

Revenue (TTM)

APLM$0

GOSS$53M

Revenue Growth (YoY)

APLMN/A

GOSS32.4%

Forward Rev Growth

APLM0.0%

GOSS50.5%

Gross Margin (TTM)

APLM0.0%

GOSS0.0%

Operating Margin (TTM)

APLM0.0%

GOSS0.0%

EBITDA Margin (TTM)

APLM0.0%

GOSS-297.6%

Net Margin (TTM)

APLM0.0%

GOSS-235.0%

FCF Margin (TTM)

APLMN/A

GOSS-305.2%

Net Income (TTM)

APLM$-823K

GOSS$-125M

FCF (TTM)

APLM$-814K

GOSS$-163M

EPS (TTM)

APLM-$0.06

GOSS-$0.38

ROE (TTM)

APLM-69339.0%

GOSS-11877.0%

ROA (TTM)

APLM-26328.0%

GOSS-8535.0%

ROIC (TTM)

APLM-56760.0%

GOSS-2300.0%

Cash

APLM$134K

GOSS$41M

Debt

APLM$0

GOSS$36M

Net Cash/Debt

APLM$134K

GOSS$5M

Current Ratio (TTM)

APLM0.96x

GOSS0.53x

Quick Ratio (TTM)

APLM0.88x

GOSS0.46x

Debt/Equity (TTM)

APLM0.20x

GOSS6.83x

Debt/Assets (TTM)

APLM0.0%

GOSS0.0%

Interest Coverage (TTM)

APLMN/A

GOSSN/A

Net Debt/EBITDA (TTM)

APLM0.00x

GOSS0.00x

Beta

APLM1.37

GOSS2.28

52W Performance

APLM413.1%

GOSS-95.2%

YTD Performance

APLM11.4%

GOSS-96.0%

% from 52W High

APLM-49.0%

GOSS-97.0%

% from 52W Low

APLM410.7%

GOSS2.3%

Asset Turnover (TTM)

APLM0.00x

GOSS0.36x

FCF Yield (TTM)

APLM-1.7%

GOSS-3.6%

Earnings Yield (TTM)

APLM-1.7%

GOSS-2.8%

Dividend Yield (TTM)

APLMN/A

GOSSN/A

Rule of 40

APLM0.0

GOSS-272.8

EV/GP/RG

APLMN/A

GOSSN/A

Ticker research

View APLM research View GOSS research

Metric	APLM Apollomics Inc	GOSS Gossamer Bio Inc
Market & Valuation
Market Cap	$47M	$4.55B
Enterprise Value	$47M	$4.55B
Price	$21.50	$9.31
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	85.41x
EV/Sales	0.00x	85.32x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.94x	2.26x
P/FCF Ratio	N/A	N/A
EV/FCF	-57.95x	-27.95x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$53M
Revenue Growth (YoY)	N/A	32.4%
Forward Rev Growth	0.0%	50.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-297.6%
Net Margin (TTM)	0.0%	-235.0%
FCF Margin (TTM)	N/A	-305.2%
Net Income (TTM)	$-823K	$-125M
FCF (TTM)	$-814K	$-163M
EPS (TTM)	-$0.06	-$0.38
ROE (TTM)	-69339.0%	-11877.0%
ROA (TTM)	-26328.0%	-8535.0%
ROIC (TTM)	-56760.0%	-2300.0%
Financial Health
Cash	$134K	$41M
Debt	$0	$36M
Net Cash/Debt	$134K	$5M
Current Ratio (TTM)	0.96x	0.53x
Quick Ratio (TTM)	0.88x	0.46x
Debt/Equity (TTM)	0.20x	6.83x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	2.28
52W Performance	413.1%	-95.2%
YTD Performance	11.4%	-96.0%
% from 52W High	-49.0%	-97.0%
% from 52W Low	410.7%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.36x
FCF Yield (TTM)	-1.7%	-3.6%
Earnings Yield (TTM)	-1.7%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-272.8
EV/GP/RG	N/A	N/A
Ticker research	View APLM research	View GOSS research